These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 20847046

  • 21. Beta2-microglobulin amyloid fragment organization and morphology and its comparison to Abeta suggests that amyloid aggregation pathways are sequence specific.
    Zheng J, Jang H, Nussinov R.
    Biochemistry; 2008 Feb 26; 47(8):2497-509. PubMed ID: 18215070
    [Abstract] [Full Text] [Related]

  • 22. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B, Bonet J, Valls-Comamala V, Bosch-Morató M, Godoy JA, Inestrosa NC, Perálvarez-Marín A, Fernández-Busquets X, Andreu D, Oliva B, Muñoz FJ.
    J Neurosci; 2016 Nov 16; 36(46):11693-11703. PubMed ID: 27852777
    [Abstract] [Full Text] [Related]

  • 23. Aβ(39-42) modulates Aβ oligomerization but not fibril formation.
    Gessel MM, Wu C, Li H, Bitan G, Shea JE, Bowers MT.
    Biochemistry; 2012 Jan 10; 51(1):108-17. PubMed ID: 22129303
    [Abstract] [Full Text] [Related]

  • 24. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y, Matsuda I, Inoue M, Sasahara T, Hoshi M, Ishii Y.
    J Biol Chem; 2020 Jan 10; 295(2):458-467. PubMed ID: 31771980
    [Abstract] [Full Text] [Related]

  • 25. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
    Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP.
    Proc Natl Acad Sci U S A; 2013 Jun 11; 110(24):9758-63. PubMed ID: 23703910
    [Abstract] [Full Text] [Related]

  • 26. Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation.
    Tsigelny IF, Sharikov Y, Kouznetsova VL, Greenberg JP, Wrasidlo W, Gonzalez T, Desplats P, Michael SE, Trejo-Morales M, Overk CR, Masliah E.
    J Alzheimers Dis; 2014 Jun 11; 39(3):583-600. PubMed ID: 24240640
    [Abstract] [Full Text] [Related]

  • 27. Understanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface.
    Barz B, Strodel B.
    Chemistry; 2016 Jun 20; 22(26):8768-72. PubMed ID: 27135646
    [Abstract] [Full Text] [Related]

  • 28. Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
    Mitternacht S, Staneva I, Härd T, Irbäck A.
    J Mol Biol; 2011 Jul 08; 410(2):357-67. PubMed ID: 21616081
    [Abstract] [Full Text] [Related]

  • 29. Self-Assembly Pathways of β-Sheet-Rich Amyloid-β(1-40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations.
    Cao Y, Jiang X, Han W.
    J Chem Theory Comput; 2017 Nov 14; 13(11):5731-5744. PubMed ID: 29019683
    [Abstract] [Full Text] [Related]

  • 30. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
    Fu Z, Van Nostrand WE, Smith SO.
    Int J Mol Sci; 2021 Jan 27; 22(3):. PubMed ID: 33513738
    [Abstract] [Full Text] [Related]

  • 31. Kinetic and thermodynamic stability comparison for the fibrillar form of small amyloid-β(1-42) oligomers using scaled molecular dynamics.
    Saha D, Jana B.
    Phys Chem Chem Phys; 2021 Aug 12; 23(31):16897-16908. PubMed ID: 34328153
    [Abstract] [Full Text] [Related]

  • 32. Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities.
    Zheng J, Jang H, Ma B, Tsai CJ, Nussinov R.
    Biophys J; 2007 Nov 01; 93(9):3046-57. PubMed ID: 17675353
    [Abstract] [Full Text] [Related]

  • 33. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
    van Gerresheim EF, Herring A, Gremer L, Müller-Schiffmann A, Keyvani K, Korth C.
    Neuropathol Appl Neurobiol; 2021 Aug 01; 47(5):603-610. PubMed ID: 33338256
    [Abstract] [Full Text] [Related]

  • 34. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P, Derreumaux P.
    Acc Chem Res; 2014 Feb 18; 47(2):603-11. PubMed ID: 24368046
    [Abstract] [Full Text] [Related]

  • 35. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
    Necula M, Kayed R, Milton S, Glabe CG.
    J Biol Chem; 2007 Apr 06; 282(14):10311-24. PubMed ID: 17284452
    [Abstract] [Full Text] [Related]

  • 36. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation.
    Jeong JS, Ansaloni A, Mezzenga R, Lashuel HA, Dietler G.
    J Mol Biol; 2013 May 27; 425(10):1765-81. PubMed ID: 23415897
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.
    Lee MC, Yu WC, Shih YH, Chen CY, Guo ZH, Huang SJ, Chan JCC, Chen YR.
    Sci Rep; 2018 Mar 19; 8(1):4772. PubMed ID: 29555950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.